NEXGEL, Inc. (NASDAQ: NXGLW) Stock Competitors & Peer Comparison
See NXGLW's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Instruments & Supplies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for NXGLW and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| NXGLW | $0.01 | +0.00% | 961.5K | -0.02 | -$0.71 | N/A |
| ISRG | $405.18 | +1.42% | 143.1B | 42.12 | $9.62 | N/A |
| BDXA | $59.24 | -2.24% | 55.9B | 45.70 | $1.30 | +2.17% |
| BDX | $183.82 | +2.56% | 50.6B | 14.14 | $13.00 | +2.17% |
| RMD | $222.00 | +0.05% | 32.2B | 20.62 | $10.77 | +1.11% |
| MDLN | $34.70 | +0.12% | 29.3B | 25.43 | $1.36 | N/A |
| WST | $370.44 | -0.85% | 26.1B | 43.58 | $8.50 | +0.24% |
| HOLX | $76.01 | +0.00% | 17B | 31.54 | $2.41 | N/A |
| SOLV | $89.50 | +1.03% | 15.5B | 12.61 | $7.10 | N/A |
| BDXB | $48.16 | +1.39% | 13.7B | 7.60 | $6.33 | +2.17% |
Stock Comparison
Intuitive Surgical, Inc. (NASDAQ: ISRG)
NXGLW vs ISRG Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, ISRG has a market cap of 143.1B. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while ISRG trades at $405.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas ISRG's P/E ratio is 42.12. In terms of profitability, NXGLW's ROE is -1.33%, compared to ISRG's ROE of +0.18%. Regarding short-term risk, NXGLW is less volatile compared to ISRG. This indicates lower risk in terms of short-term price fluctuations for NXGLW.Check ISRG's competition here
Becton, Dickinson and Company (NYSE: BDXA)
NXGLW vs BDXA Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, BDXA has a market cap of 55.9B. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while BDXA trades at $59.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas BDXA's P/E ratio is 45.70. In terms of profitability, NXGLW's ROE is -1.33%, compared to BDXA's ROE of +0.04%. Regarding short-term risk, NXGLW is less volatile compared to BDXA. This indicates lower risk in terms of short-term price fluctuations for NXGLW.Check BDXA's competition here
Becton, Dickinson and Company (NYSE: BDX)
NXGLW vs BDX Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, BDX has a market cap of 50.6B. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while BDX trades at $183.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas BDX's P/E ratio is 14.14. In terms of profitability, NXGLW's ROE is -1.33%, compared to BDX's ROE of +0.04%. Regarding short-term risk, NXGLW is less volatile compared to BDX. This indicates lower risk in terms of short-term price fluctuations for NXGLW.Check BDX's competition here
ResMed Inc. (NYSE: RMD)
NXGLW vs RMD Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, RMD has a market cap of 32.2B. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while RMD trades at $222.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas RMD's P/E ratio is 20.62. In terms of profitability, NXGLW's ROE is -1.33%, compared to RMD's ROE of +0.24%. Regarding short-term risk, NXGLW is more volatile compared to RMD. This indicates higher risk in terms of short-term price fluctuations for NXGLW.Check RMD's competition here
Medline Inc. (NASDAQ: MDLN)
NXGLW vs MDLN Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, MDLN has a market cap of 29.3B. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while MDLN trades at $34.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas MDLN's P/E ratio is 25.43. In terms of profitability, NXGLW's ROE is -1.33%, compared to MDLN's ROE of +0.05%. Regarding short-term risk, NXGLW is less volatile compared to MDLN. This indicates lower risk in terms of short-term price fluctuations for NXGLW.Check MDLN's competition here
West Pharmaceutical Services, Inc. (NYSE: WST)
NXGLW vs WST Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, WST has a market cap of 26.1B. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while WST trades at $370.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas WST's P/E ratio is 43.58. In terms of profitability, NXGLW's ROE is -1.33%, compared to WST's ROE of +0.19%. Regarding short-term risk, NXGLW is more volatile compared to WST. This indicates higher risk in terms of short-term price fluctuations for NXGLW.Check WST's competition here
Hologic, Inc. (NASDAQ: HOLX)
NXGLW vs HOLX Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, HOLX has a market cap of 17B. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while HOLX trades at $76.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas HOLX's P/E ratio is 31.54. In terms of profitability, NXGLW's ROE is -1.33%, compared to HOLX's ROE of +0.11%. Regarding short-term risk, NXGLW is more volatile compared to HOLX. This indicates higher risk in terms of short-term price fluctuations for NXGLW.Check HOLX's competition here
Solventum Corporation (NYSE: SOLV)
NXGLW vs SOLV Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, SOLV has a market cap of 15.5B. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while SOLV trades at $89.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas SOLV's P/E ratio is 12.61. In terms of profitability, NXGLW's ROE is -1.33%, compared to SOLV's ROE of +0.29%. Regarding short-term risk, NXGLW is less volatile compared to SOLV. This indicates lower risk in terms of short-term price fluctuations for NXGLW.Check SOLV's competition here
Becton, Dickinson and Company (NYSE: BDXB)
NXGLW vs BDXB Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, BDXB has a market cap of 13.7B. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while BDXB trades at $48.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas BDXB's P/E ratio is 7.60. In terms of profitability, NXGLW's ROE is -1.33%, compared to BDXB's ROE of +0.04%. Regarding short-term risk, NXGLW is less volatile compared to BDXB. This indicates lower risk in terms of short-term price fluctuations for NXGLW.Check BDXB's competition here
Baxter International Inc. (NYSE: BAX)
NXGLW vs BAX Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, BAX has a market cap of 12.1B. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while BAX trades at $23.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas BAX's P/E ratio is 11.24. In terms of profitability, NXGLW's ROE is -1.33%, compared to BAX's ROE of -0.17%. Regarding short-term risk, NXGLW is less volatile compared to BAX. This indicates lower risk in terms of short-term price fluctuations for NXGLW.Check BAX's competition here
The Cooper Companies, Inc. (NASDAQ: COO)
NXGLW vs COO Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, COO has a market cap of 10.8B. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while COO trades at $55.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas COO's P/E ratio is 12.14. In terms of profitability, NXGLW's ROE is -1.33%, compared to COO's ROE of +0.07%. Regarding short-term risk, NXGLW is less volatile compared to COO. This indicates lower risk in terms of short-term price fluctuations for NXGLW.Check COO's competition here
Repligen Corporation (NASDAQ: RGEN)
NXGLW vs RGEN Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, RGEN has a market cap of 10.7B. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while RGEN trades at $189.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas RGEN's P/E ratio is 105.38. In terms of profitability, NXGLW's ROE is -1.33%, compared to RGEN's ROE of +0.02%. Regarding short-term risk, NXGLW is less volatile compared to RGEN. This indicates lower risk in terms of short-term price fluctuations for NXGLW.Check RGEN's competition here
Avantor, Inc. (NYSE: AVTR)
NXGLW vs AVTR Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, AVTR has a market cap of 10.3B. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while AVTR trades at $15.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas AVTR's P/E ratio is 17.95. In terms of profitability, NXGLW's ROE is -1.33%, compared to AVTR's ROE of -0.10%. Regarding short-term risk, NXGLW is less volatile compared to AVTR. This indicates lower risk in terms of short-term price fluctuations for NXGLW.Check AVTR's competition here
AptarGroup, Inc. (NYSE: ATR)
NXGLW vs ATR Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, ATR has a market cap of 7.9B. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while ATR trades at $123.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas ATR's P/E ratio is 21.65. In terms of profitability, NXGLW's ROE is -1.33%, compared to ATR's ROE of +0.14%. Regarding short-term risk, NXGLW is more volatile compared to ATR. This indicates higher risk in terms of short-term price fluctuations for NXGLW.Check ATR's competition here
Bausch + Lomb Corporation (NYSE: BLCO)
NXGLW vs BLCO Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, BLCO has a market cap of 6B. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while BLCO trades at $16.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas BLCO's P/E ratio is 25.94. In terms of profitability, NXGLW's ROE is -1.33%, compared to BLCO's ROE of -0.03%. Regarding short-term risk, NXGLW is more volatile compared to BLCO. This indicates higher risk in terms of short-term price fluctuations for NXGLW.Check BLCO's competition here
Stevanato Group S.p.A. (NYSE: STVN)
NXGLW vs STVN Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, STVN has a market cap of 5.8B. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while STVN trades at $21.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas STVN's P/E ratio is 32.13. In terms of profitability, NXGLW's ROE is -1.33%, compared to STVN's ROE of +0.09%. Regarding short-term risk, NXGLW is less volatile compared to STVN. This indicates lower risk in terms of short-term price fluctuations for NXGLW.Check STVN's competition here
Teleflex Incorporated (NYSE: TFX)
NXGLW vs TFX Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, TFX has a market cap of 5.4B. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while TFX trades at $122.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas TFX's P/E ratio is 13.96. In terms of profitability, NXGLW's ROE is -1.33%, compared to TFX's ROE of -0.32%. Regarding short-term risk, NXGLW is less volatile compared to TFX. This indicates lower risk in terms of short-term price fluctuations for NXGLW.Check TFX's competition here
Merit Medical Systems, Inc. (NASDAQ: MMSI)
NXGLW vs MMSI Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, MMSI has a market cap of 5.2B. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while MMSI trades at $87.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas MMSI's P/E ratio is 22.38. In terms of profitability, NXGLW's ROE is -1.33%, compared to MMSI's ROE of +0.09%. Regarding short-term risk, NXGLW is more volatile compared to MMSI. This indicates higher risk in terms of short-term price fluctuations for NXGLW.Check MMSI's competition here
ICU Medical, Inc. (NASDAQ: ICUI)
NXGLW vs ICUI Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, ICUI has a market cap of 4.1B. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while ICUI trades at $164.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas ICUI's P/E ratio is 20.59. In terms of profitability, NXGLW's ROE is -1.33%, compared to ICUI's ROE of +0.01%. Regarding short-term risk, NXGLW is less volatile compared to ICUI. This indicates lower risk in terms of short-term price fluctuations for NXGLW.Check ICUI's competition here
Envista Holdings Corp (NYSE: NVST)
NXGLW vs NVST Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, NVST has a market cap of 3.9B. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while NVST trades at $23.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas NVST's P/E ratio is 16.30. In terms of profitability, NXGLW's ROE is -1.33%, compared to NVST's ROE of +0.03%. Regarding short-term risk, NXGLW is less volatile compared to NVST. This indicates lower risk in terms of short-term price fluctuations for NXGLW.Check NVST's competition here
Pulse Biosciences, Inc. (NASDAQ: PLSE)
NXGLW vs PLSE Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, PLSE has a market cap of 3.6B. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while PLSE trades at $51.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas PLSE's P/E ratio is -43.75. In terms of profitability, NXGLW's ROE is -1.33%, compared to PLSE's ROE of -0.94%. Regarding short-term risk, NXGLW is less volatile compared to PLSE. This indicates lower risk in terms of short-term price fluctuations for NXGLW.Check PLSE's competition here
AtriCure, Inc. (NASDAQ: ATRC)
NXGLW vs ATRC Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, ATRC has a market cap of 3B. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while ATRC trades at $58.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas ATRC's P/E ratio is 1813.04. In terms of profitability, NXGLW's ROE is -1.33%, compared to ATRC's ROE of +0.02%. Regarding short-term risk, NXGLW is less volatile compared to ATRC. This indicates lower risk in terms of short-term price fluctuations for NXGLW.Check ATRC's competition here
DENTSPLY SIRONA Inc. (NASDAQ: XRAY)
NXGLW vs XRAY Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, XRAY has a market cap of 1.9B. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while XRAY trades at $9.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas XRAY's P/E ratio is 6.57. In terms of profitability, NXGLW's ROE is -1.33%, compared to XRAY's ROE of -0.40%. Regarding short-term risk, NXGLW is less volatile compared to XRAY. This indicates lower risk in terms of short-term price fluctuations for NXGLW.Check XRAY's competition here
BioLife Solutions, Inc. (NASDAQ: BLFS)
NXGLW vs BLFS Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, BLFS has a market cap of 1.9B. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while BLFS trades at $38.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas BLFS's P/E ratio is 37.37. In terms of profitability, NXGLW's ROE is -1.33%, compared to BLFS's ROE of +0.13%. Regarding short-term risk, NXGLW is more volatile compared to BLFS. This indicates higher risk in terms of short-term price fluctuations for NXGLW.Check BLFS's competition here
LeMaitre Vascular, Inc. (NASDAQ: LMAT)
NXGLW vs LMAT Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, LMAT has a market cap of 1.9B. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while LMAT trades at $81.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas LMAT's P/E ratio is 29.97. In terms of profitability, NXGLW's ROE is -1.33%, compared to LMAT's ROE of +0.16%. Regarding short-term risk, NXGLW is less volatile compared to LMAT. This indicates lower risk in terms of short-term price fluctuations for NXGLW.Check LMAT's competition here
Kestra Medical Technologies, Ltd. (NASDAQ: KMTS)
NXGLW vs KMTS Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, KMTS has a market cap of 1.6B. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while KMTS trades at $27.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas KMTS's P/E ratio is -10.24. In terms of profitability, NXGLW's ROE is -1.33%, compared to KMTS's ROE of -0.64%. Regarding short-term risk, NXGLW is less volatile compared to KMTS. This indicates lower risk in terms of short-term price fluctuations for NXGLW.Check KMTS's competition here
Azenta, Inc. (NASDAQ: AZTA)
NXGLW vs AZTA Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, AZTA has a market cap of 1.6B. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while AZTA trades at $34.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas AZTA's P/E ratio is 81.00. In terms of profitability, NXGLW's ROE is -1.33%, compared to AZTA's ROE of -0.08%. Regarding short-term risk, NXGLW is less volatile compared to AZTA. This indicates lower risk in terms of short-term price fluctuations for NXGLW.Check AZTA's competition here
STAAR Surgical Company (NASDAQ: STAA)
NXGLW vs STAA Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, STAA has a market cap of 1B. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while STAA trades at $20.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas STAA's P/E ratio is 35.98. In terms of profitability, NXGLW's ROE is -1.33%, compared to STAA's ROE of +0.01%. Regarding short-term risk, NXGLW is less volatile compared to STAA. This indicates lower risk in terms of short-term price fluctuations for NXGLW.Check STAA's competition here
Atrion Corporation (NASDAQ: ATRI)
NXGLW vs ATRI Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, ATRI has a market cap of 809.4M. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while ATRI trades at $459.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas ATRI's P/E ratio is 64.50. In terms of profitability, NXGLW's ROE is -1.33%, compared to ATRI's ROE of +0.08%. Regarding short-term risk, NXGLW is more volatile compared to ATRI. This indicates higher risk in terms of short-term price fluctuations for NXGLW.Check ATRI's competition here
AngioDynamics, Inc. (NASDAQ: ANGO)
NXGLW vs ANGO Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, ANGO has a market cap of 640.2M. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while ANGO trades at $15.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas ANGO's P/E ratio is -39.72. In terms of profitability, NXGLW's ROE is -1.33%, compared to ANGO's ROE of -0.21%. Regarding short-term risk, NXGLW is less volatile compared to ANGO. This indicates lower risk in terms of short-term price fluctuations for NXGLW.Check ANGO's competition here
Embecta Corp. (NASDAQ: EMBC)
NXGLW vs EMBC Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, EMBC has a market cap of 350M. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while EMBC trades at $5.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas EMBC's P/E ratio is 2.27. In terms of profitability, NXGLW's ROE is -1.33%, compared to EMBC's ROE of -0.14%. Regarding short-term risk, NXGLW is less volatile compared to EMBC. This indicates lower risk in terms of short-term price fluctuations for NXGLW.Check EMBC's competition here
Sanara MedTech Inc. (NASDAQ: SMTI)
NXGLW vs SMTI Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, SMTI has a market cap of 322.3M. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while SMTI trades at $35.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas SMTI's P/E ratio is -584.33. In terms of profitability, NXGLW's ROE is -1.33%, compared to SMTI's ROE of -4.74%. Regarding short-term risk, NXGLW is more volatile compared to SMTI. This indicates higher risk in terms of short-term price fluctuations for NXGLW.Check SMTI's competition here
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN)
NXGLW vs NNNN Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, NNNN has a market cap of 276.5M. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while NNNN trades at $6.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas NNNN's P/E ratio is 38.49. In terms of profitability, NXGLW's ROE is -1.33%, compared to NNNN's ROE of +0.27%. Regarding short-term risk, NXGLW is less volatile compared to NNNN. This indicates lower risk in terms of short-term price fluctuations for NXGLW.Check NNNN's competition here
OraSure Technologies, Inc. (NASDAQ: OSUR)
NXGLW vs OSUR Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, OSUR has a market cap of 270.6M. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while OSUR trades at $3.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas OSUR's P/E ratio is -5.70. In terms of profitability, NXGLW's ROE is -1.33%, compared to OSUR's ROE of -0.15%. Regarding short-term risk, NXGLW is less volatile compared to OSUR. This indicates lower risk in terms of short-term price fluctuations for NXGLW.Check OSUR's competition here
Utah Medical Products, Inc. (NASDAQ: UTMD)
NXGLW vs UTMD Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, UTMD has a market cap of 236.2M. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while UTMD trades at $74.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas UTMD's P/E ratio is 21.95. In terms of profitability, NXGLW's ROE is -1.33%, compared to UTMD's ROE of +0.09%. Regarding short-term risk, NXGLW is more volatile compared to UTMD. This indicates higher risk in terms of short-term price fluctuations for NXGLW.Check UTMD's competition here
Pro-Dex, Inc. (NASDAQ: PDEX)
NXGLW vs PDEX Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, PDEX has a market cap of 229.1M. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while PDEX trades at $71.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas PDEX's P/E ratio is 17.38. In terms of profitability, NXGLW's ROE is -1.33%, compared to PDEX's ROE of +0.31%. Regarding short-term risk, NXGLW is less volatile compared to PDEX. This indicates lower risk in terms of short-term price fluctuations for NXGLW.Check PDEX's competition here
KORU Medical Systems, Inc. (NASDAQ: KRMD)
NXGLW vs KRMD Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, KRMD has a market cap of 147.4M. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while KRMD trades at $3.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas KRMD's P/E ratio is -80.25. In terms of profitability, NXGLW's ROE is -1.33%, compared to KRMD's ROE of -0.11%. Regarding short-term risk, NXGLW is less volatile compared to KRMD. This indicates lower risk in terms of short-term price fluctuations for NXGLW.Check KRMD's competition here
Stereotaxis, Inc. (AMEX: STXS)
NXGLW vs STXS Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, STXS has a market cap of 127.8M. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while STXS trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas STXS's P/E ratio is -7.68. In terms of profitability, NXGLW's ROE is -1.33%, compared to STXS's ROE of -1.33%. Regarding short-term risk, NXGLW is less volatile compared to STXS. This indicates lower risk in terms of short-term price fluctuations for NXGLW.Check STXS's competition here
Daxor Corporation (NASDAQ: DXR)
NXGLW vs DXR Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, DXR has a market cap of 66.4M. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while DXR trades at $11.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas DXR's P/E ratio is 9.25. In terms of profitability, NXGLW's ROE is -1.33%, compared to DXR's ROE of +0.13%. Regarding short-term risk, NXGLW is less volatile compared to DXR. This indicates lower risk in terms of short-term price fluctuations for NXGLW.Check DXR's competition here
Akoya Biosciences, Inc. (NASDAQ: AKYA)
NXGLW vs AKYA Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, AKYA has a market cap of 64.4M. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while AKYA trades at $1.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas AKYA's P/E ratio is -1.34. In terms of profitability, NXGLW's ROE is -1.33%, compared to AKYA's ROE of -1.80%. Regarding short-term risk, NXGLW is more volatile compared to AKYA. This indicates higher risk in terms of short-term price fluctuations for NXGLW.Check AKYA's competition here
SkyAI, Inc. (NASDAQ: STSS)
NXGLW vs STSS Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, STSS has a market cap of 53.7M. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while STSS trades at $1.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas STSS's P/E ratio is -0.02. In terms of profitability, NXGLW's ROE is -1.33%, compared to STSS's ROE of -1.54%. Regarding short-term risk, NXGLW is less volatile compared to STSS. This indicates lower risk in terms of short-term price fluctuations for NXGLW.Check STSS's competition here
Singular Genomics Systems, Inc. (NASDAQ: OMIC)
NXGLW vs OMIC Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, OMIC has a market cap of 50.8M. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while OMIC trades at $20.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas OMIC's P/E ratio is -0.58. In terms of profitability, NXGLW's ROE is -1.33%, compared to OMIC's ROE of -0.43%. Regarding short-term risk, NXGLW is more volatile compared to OMIC. This indicates higher risk in terms of short-term price fluctuations for NXGLW.Check OMIC's competition here
Precision Optics Corporation, Inc. (NASDAQ: POCI)
NXGLW vs POCI Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, POCI has a market cap of 50.7M. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while POCI trades at $4.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas POCI's P/E ratio is -7.35. In terms of profitability, NXGLW's ROE is -1.33%, compared to POCI's ROE of -0.37%. Regarding short-term risk, NXGLW is less volatile compared to POCI. This indicates lower risk in terms of short-term price fluctuations for NXGLW.Check POCI's competition here
GlucoTrack, Inc. (NASDAQ: IGAP)
NXGLW vs IGAP Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, IGAP has a market cap of 50.2M. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while IGAP trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas IGAP's P/E ratio is -10.52. In terms of profitability, NXGLW's ROE is -1.33%, compared to IGAP's ROE of +1.80%. Regarding short-term risk, NXGLW is less volatile compared to IGAP. This indicates lower risk in terms of short-term price fluctuations for NXGLW.Check IGAP's competition here
Nephros, Inc. (NASDAQ: NEPH)
NXGLW vs NEPH Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, NEPH has a market cap of 46.6M. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while NEPH trades at $4.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas NEPH's P/E ratio is 71.50. In terms of profitability, NXGLW's ROE is -1.33%, compared to NEPH's ROE of +0.16%. Regarding short-term risk, NXGLW is less volatile compared to NEPH. This indicates lower risk in terms of short-term price fluctuations for NXGLW.Check NEPH's competition here
Milestone Scientific Inc. (AMEX: MLSS)
NXGLW vs MLSS Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, MLSS has a market cap of 36.3M. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while MLSS trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas MLSS's P/E ratio is -8.21. In terms of profitability, NXGLW's ROE is -1.33%, compared to MLSS's ROE of -1.49%. Regarding short-term risk, NXGLW is less volatile compared to MLSS. This indicates lower risk in terms of short-term price fluctuations for NXGLW.Check MLSS's competition here
Harvard Bioscience, Inc. (NASDAQ: HBIO)
NXGLW vs HBIO Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, HBIO has a market cap of 35.9M. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while HBIO trades at $7.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas HBIO's P/E ratio is -22.08. In terms of profitability, NXGLW's ROE is -1.33%, compared to HBIO's ROE of -0.92%. Regarding short-term risk, NXGLW is similarly volatile compared to HBIO. This indicates similar risk in terms of short-term price fluctuations for NXGLW.Check HBIO's competition here
SmileDirectClub, Inc. (NASDAQ: SDC)
NXGLW vs SDC Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, SDC has a market cap of 29.1M. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while SDC trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas SDC's P/E ratio is -0.03. In terms of profitability, NXGLW's ROE is -1.33%, compared to SDC's ROE of -1.96%. Regarding short-term risk, NXGLW is less volatile compared to SDC. This indicates lower risk in terms of short-term price fluctuations for NXGLW.Check SDC's competition here
Invacare Corporation (NYSE: IVC)
NXGLW vs IVC Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, IVC has a market cap of 24.9M. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while IVC trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas IVC's P/E ratio is -0.79. In terms of profitability, NXGLW's ROE is -1.33%, compared to IVC's ROE of -0.46%. Regarding short-term risk, NXGLW is less volatile compared to IVC. This indicates lower risk in terms of short-term price fluctuations for NXGLW.Check IVC's competition here
Retractable Technologies, Inc. (AMEX: RVP)
NXGLW vs RVP Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, RVP has a market cap of 20.7M. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while RVP trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas RVP's P/E ratio is -5.76. In terms of profitability, NXGLW's ROE is -1.33%, compared to RVP's ROE of -0.05%. Regarding short-term risk, NXGLW is less volatile compared to RVP. This indicates lower risk in terms of short-term price fluctuations for NXGLW.Check RVP's competition here
Bionano Genomics, Inc. (NASDAQ: BNGO)
NXGLW vs BNGO Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, BNGO has a market cap of 19M. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while BNGO trades at $1.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas BNGO's P/E ratio is -0.55. In terms of profitability, NXGLW's ROE is -1.33%, compared to BNGO's ROE of -0.79%. Regarding short-term risk, NXGLW is less volatile compared to BNGO. This indicates lower risk in terms of short-term price fluctuations for NXGLW.Check BNGO's competition here
Jin Medical International Ltd. (NASDAQ: ZJYL)
NXGLW vs ZJYL Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, ZJYL has a market cap of 15.7M. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while ZJYL trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas ZJYL's P/E ratio is 13.68. In terms of profitability, NXGLW's ROE is -1.33%, compared to ZJYL's ROE of +0.04%. Regarding short-term risk, NXGLW is less volatile compared to ZJYL. This indicates lower risk in terms of short-term price fluctuations for NXGLW.Check ZJYL's competition here
Regentis Biomaterials Ltd. (AMEX: RGNT)
NXGLW vs RGNT Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, RGNT has a market cap of 13.8M. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while RGNT trades at $1.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas RGNT's P/E ratio is -0.08. In terms of profitability, NXGLW's ROE is -1.33%, compared to RGNT's ROE of N/A. Regarding short-term risk, NXGLW is less volatile compared to RGNT. This indicates lower risk in terms of short-term price fluctuations for NXGLW.Check RGNT's competition here
Femasys Inc. (NASDAQ: FEMY)
NXGLW vs FEMY Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, FEMY has a market cap of 7.5M. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while FEMY trades at $2.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas FEMY's P/E ratio is -0.55. In terms of profitability, NXGLW's ROE is -1.33%, compared to FEMY's ROE of -2.26%. Regarding short-term risk, NXGLW is less volatile compared to FEMY. This indicates lower risk in terms of short-term price fluctuations for NXGLW.Check FEMY's competition here
Lucyd, Inc (NASDAQ: LUCY)
NXGLW vs LUCY Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, LUCY has a market cap of 6M. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while LUCY trades at $0.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas LUCY's P/E ratio is -0.74. In terms of profitability, NXGLW's ROE is -1.33%, compared to LUCY's ROE of -0.89%. Regarding short-term risk, NXGLW is less volatile compared to LUCY. This indicates lower risk in terms of short-term price fluctuations for NXGLW.Check LUCY's competition here
NanoString Technologies, Inc. (NASDAQ: NSTG)
NXGLW vs NSTG Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, NSTG has a market cap of 5.1M. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while NSTG trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas NSTG's P/E ratio is -0.03. In terms of profitability, NXGLW's ROE is -1.33%, compared to NSTG's ROE of -1.43%. Regarding short-term risk, NXGLW is less volatile compared to NSTG. This indicates lower risk in terms of short-term price fluctuations for NXGLW.Check NSTG's competition here
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (NASDAQ: CUPR)
NXGLW vs CUPR Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, CUPR has a market cap of 4.9M. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while CUPR trades at $1.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas CUPR's P/E ratio is -1.33. In terms of profitability, NXGLW's ROE is -1.33%, compared to CUPR's ROE of -15.69%. Regarding short-term risk, NXGLW is less volatile compared to CUPR. This indicates lower risk in terms of short-term price fluctuations for NXGLW.Check CUPR's competition here
Predictive Oncology Inc. (NASDAQ: POAI)
NXGLW vs POAI Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, POAI has a market cap of 3.6M. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while POAI trades at $4.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas POAI's P/E ratio is -0.03. In terms of profitability, NXGLW's ROE is -1.33%, compared to POAI's ROE of -21.19%. Regarding short-term risk, NXGLW is less volatile compared to POAI. This indicates lower risk in terms of short-term price fluctuations for NXGLW.Check POAI's competition here
Meihua International Medical Technologies Co., Ltd. (NASDAQ: MHUA)
NXGLW vs MHUA Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, MHUA has a market cap of 2.4M. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while MHUA trades at $7.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas MHUA's P/E ratio is 0.25. In terms of profitability, NXGLW's ROE is -1.33%, compared to MHUA's ROE of +0.07%. Regarding short-term risk, NXGLW is more volatile compared to MHUA. This indicates higher risk in terms of short-term price fluctuations for NXGLW.Check MHUA's competition here
G Medical Innovations Holdings Ltd (NASDAQ: GMVD)
NXGLW vs GMVD Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, GMVD has a market cap of 1.8M. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while GMVD trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas GMVD's P/E ratio is -0.01. In terms of profitability, NXGLW's ROE is -1.33%, compared to GMVD's ROE of +2.09%. Regarding short-term risk, NXGLW is less volatile compared to GMVD. This indicates lower risk in terms of short-term price fluctuations for NXGLW.Check GMVD's competition here
G Medical Innovations Holdings Ltd (NASDAQ: GMVDW)
NXGLW vs GMVDW Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, GMVDW has a market cap of 1.8M. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while GMVDW trades at $7.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas GMVDW's P/E ratio is N/A. In terms of profitability, NXGLW's ROE is -1.33%, compared to GMVDW's ROE of +2.09%. Regarding short-term risk, NXGLW is less volatile compared to GMVDW. This indicates lower risk in terms of short-term price fluctuations for NXGLW.Check GMVDW's competition here
Avinger, Inc. (NASDAQ: AVGR)
NXGLW vs AVGR Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, AVGR has a market cap of 1.5M. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while AVGR trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas AVGR's P/E ratio is -0.05. In terms of profitability, NXGLW's ROE is -1.33%, compared to AVGR's ROE of +17.82%. Regarding short-term risk, NXGLW is less volatile compared to AVGR. This indicates lower risk in terms of short-term price fluctuations for NXGLW.Check AVGR's competition here
NEXGEL, Inc. (NASDAQ: NXGL)
NXGLW vs NXGL Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, NXGL has a market cap of 1.5M. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while NXGL trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas NXGL's P/E ratio is -0.25. In terms of profitability, NXGLW's ROE is -1.33%, compared to NXGL's ROE of -1.33%. Regarding short-term risk, NXGLW is less volatile compared to NXGL. This indicates lower risk in terms of short-term price fluctuations for NXGLW.Check NXGL's competition here
Lucyd, Inc (NASDAQ: LUCYW)
NXGLW vs LUCYW Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, LUCYW has a market cap of 296.1K. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while LUCYW trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas LUCYW's P/E ratio is N/A. In terms of profitability, NXGLW's ROE is -1.33%, compared to LUCYW's ROE of -0.89%. Regarding short-term risk, NXGLW is less volatile compared to LUCYW. This indicates lower risk in terms of short-term price fluctuations for NXGLW.Check LUCYW's competition here
Antares Pharma, Inc. (NASDAQ: ATRS)
NXGLW vs ATRS Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, ATRS has a market cap of 0. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while ATRS trades at $5.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas ATRS's P/E ratio is 14.95. In terms of profitability, NXGLW's ROE is -1.33%, compared to ATRS's ROE of +0.31%. Regarding short-term risk, NXGLW is more volatile compared to ATRS. This indicates higher risk in terms of short-term price fluctuations for NXGLW.Check ATRS's competition here
IntriCon Corporation (NASDAQ: IIN)
NXGLW vs IIN Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, IIN has a market cap of 0. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while IIN trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas IIN's P/E ratio is 226.45. In terms of profitability, NXGLW's ROE is -1.33%, compared to IIN's ROE of -0.00%. Regarding short-term risk, NXGLW is more volatile compared to IIN. This indicates higher risk in terms of short-term price fluctuations for NXGLW.Check IIN's competition here
Analogic Corporation (NASDAQ: ALOG)
NXGLW vs ALOG Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, ALOG has a market cap of 0. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while ALOG trades at $83.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas ALOG's P/E ratio is 40.93. In terms of profitability, NXGLW's ROE is -1.33%, compared to ALOG's ROE of -0.15%. Regarding short-term risk, NXGLW is more volatile compared to ALOG. This indicates higher risk in terms of short-term price fluctuations for NXGLW.Check ALOG's competition here
Apria, Inc. (NASDAQ: APR)
NXGLW vs APR Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, APR has a market cap of 0. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while APR trades at $37.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas APR's P/E ratio is 22.59. In terms of profitability, NXGLW's ROE is -1.33%, compared to APR's ROE of +9.81%. Regarding short-term risk, NXGLW is more volatile compared to APR. This indicates higher risk in terms of short-term price fluctuations for NXGLW.Check APR's competition here
Invuity, Inc. (NASDAQ: IVTY)
NXGLW vs IVTY Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, IVTY has a market cap of 0. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while IVTY trades at $7.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas IVTY's P/E ratio is -3.80. In terms of profitability, NXGLW's ROE is -1.33%, compared to IVTY's ROE of -2.40%. Regarding short-term risk, NXGLW is more volatile compared to IVTY. This indicates higher risk in terms of short-term price fluctuations for NXGLW.Check IVTY's competition here
Hill-Rom Holdings, Inc. (NYSE: HRC)
NXGLW vs HRC Comparison September 2026
NEXGEL, Inc. (NASDAQ: NXGLW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 961.5K. In comparison, HRC has a market cap of 0. Regarding current trading prices, NXGLW is priced at $0.01 on the NASDAQ, while HRC trades at $155.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.02, whereas HRC's P/E ratio is 41.92. In terms of profitability, NXGLW's ROE is -1.33%, compared to HRC's ROE of +0.14%. Regarding short-term risk, NXGLW is more volatile compared to HRC. This indicates higher risk in terms of short-term price fluctuations for NXGLW.Check HRC's competition here